NEWS AND VIEWS FROM THE PHARMACEUTICAL FINE CHEMICAL AND CUSTOM MANUFACTURING SECTOR

Tuesday 5 February 2013

Ben Venue restrained from manufacturing

Boehringer Ingelheim's Ben Venue Laboratories Bedford, Ohio, facility will no be able to manufacture and distribute drugs until the FDA determines that its operations are compliant with the Federal Food, Drug, and Cosmetic Act.
Thomson Reuters

No comments: